Chattem Chemicals

Sun Pharma’s US subsidiary buys Chattem Chemicals

India’s leading drug firm Sun Pharmaceutical Industries Ltd has announced that it’s wholly owned US arm has bought 100 percent ownership of Chattem Chemicals, Inc. (Chattem) from Elcat, Inc, the domestic drug firm.

The conglomerate did not reveal the financial transaction of the acquisition.

According to the sources, US based Chattem is a leading narcotic raw material importer and producer.

Syndicate content